TXMD logo

TXMD
TherapeuticsMD Inc

20,560
Mkt Cap
$19.1M
Volume
268,213.00
52W High
$2.44
52W Low
$0.70
PE Ratio
63.22
TXMD Fundamentals
Price
$1.92
Prev Close
$1.65
Open
$1.59
50D MA
$1.21
Beta
0.70
Avg. Volume
447,232.70
EPS (Annual)
-$0.1891
P/B
0.70
Rev/Employee
$1.76M
Loading...
Loading...
News
all
press releases
TherapeuticsMD Announces Third Quarter 2025 Financial Results
TherapeuticsMD, Inc. (TherapeuticsMD or the Company) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the three months ended September 30...
Business Wire·8d ago
News Placeholder
More News
News Placeholder
TherapeuticsMD Announces Third Quarter 2024 Financial Results
TherapeuticsMD, Inc. (TherapeuticsMD or the Company) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the third quarter ended September 30...
Business Wire·1y ago
News Placeholder
TherapeuticsMD And 2 Other Stocks Under $2 Executives Are Buying
read more...
Benzinga·1y ago
News Placeholder
TherapeuticsMD Releases Preliminary Quarterly Financial Results
TherapeuticsMD (TXMD) has shared an update. TherapeuticsMD, Inc. recently disclosed its financial outcomes for the quarter ending June 30, 2024, th...
TipRanks Financial Blog·1y ago
News Placeholder
TherapeuticsMD Announces Second Quarter 2024 Financial Results
TherapeuticsMD, Inc. (TherapeuticsMD or the Company) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the second quarter ended June 30...
Business Wire·1y ago
News Placeholder
TherapeuticsMD Announces First Quarter 2024 Financial Results
TherapeuticsMD, Inc. (TherapeuticsMD or the Company) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the first quarter ended March 31...
Business Wire·2y ago
News Placeholder
TherapeuticsMD Announces Full Year 2023 Financial Results
TherapeuticsMD, Inc. (TherapeuticsMD or the Company) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the full year ended December 31...
Business Wire·2y ago
News Placeholder
TherapeuticsMD Announces 2023 Annual Financial Results
TherapeuticsMD (TXMD) has provided an announcement. TherapeuticsMD, Inc., a healthcare company, announced its annual financial results for 2023 on...
TipRanks Financial Blog·2y ago
News Placeholder
TherapeuticsMD (NASDAQ:TXMD) Earns Hold Rating from Analysts at StockNews.com
Analysts at StockNews.com began coverage on shares of TherapeuticsMD (NASDAQ:TXMD Get Free Report) in a research report issued on Friday. The firm set a hold rating on the...
Ticker Report·2y ago
News Placeholder
TherapeuticsMD (NASDAQ:TXMD) Coverage Initiated at StockNews.com
Investment analysts at StockNews.com started coverage on shares of TherapeuticsMD (NASDAQ:TXMD Get Free Report) in a note issued to investors on Saturday. The brokerage set a...
Zolmax·2y ago

Latest TXMD News

View

Advertisement|Remove ads.

Advertisement|Remove ads.